Researcher
Isabelle Vanden Bempt
- Disciplines:Clinical genetics and molecular diagnostics, Medical genomics, Medical transcriptomics
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Member
From24 Nov 2021 → Today - Department of Human Genetics (Department)
Member
From1 Oct 2018 → 23 Nov 2021 - Translational Cell & Tissue Research (Division)
Member
From15 Aug 2003 → 30 Sep 2008
Projects
1 - 4 of 4
- Optical genome mapping for comprehensive genetic analysis of sarcomas in a diagnostic setting.From1 Jan 2023 → TodayFunding: FWO Humanitarian research project Stand up against Cancer
- Whole-genome optical mapping for comprehensive analysis of sarcoma genomes in a diagnostic settingFrom13 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Genomic Medicine: Translation of Whole Genome Analyses to Health GenomicsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic settingFrom1 May 2017 → 14 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 46
- Fibromatosis-like metaplastic carcinoma: a case report and review of the literature(2020)
Authors: Sara Vander Borght, Isabelle Vanden Bempt, Beppe Floris
- Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.(2019)
Authors: Laurence Slembrouck, Isabelle Vanden Bempt, Sara Vander Borght, Patrick Neven, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, et al.
Pages: 1557 - 1565 - Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer (vol 38, pg 1071, 2018)(2019)
Authors: Griet Hoste, Laurence Slembrouck, Lynn Jongen, Kevin Punie, Tom Matton, Sara Vander Borght, Isabelle Vanden Bempt, Joannes Menten, Hans Wildiers, Beppe Floris, et al.
Pages: 113 - 113 - Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer(2018)
Authors: Laurence Slembrouck, Lynn Jongen, Kevin Punie, Sara Vander Borght, Isabelle Vanden Bempt, Joannes Menten, Hans Wildiers, Beppe Floris, Patrick Neven
Pages: 1071 - 1075 - Genetic profiling of cell-free DNA from cerebrospinal fluid: opening the barrier to leptomeningeal metastasis in EGFR-mutant NSCLC(2018)
Authors: Isabelle Vanden Bempt, Els Wauters, Johan Vansteenkiste
Pages: 789 - 791 - Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system(2017)
Authors: Isabelle Vanden Bempt
Pages: 253 - 263 - BRAF mutation testing with a rapid, fully integrated molecular diagnostics system(2015)
Authors: Isabelle Vanden Bempt
Pages: 26886 - 26894 - Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.(2014)
Authors: Isabelle Vanden Bempt
Pages: 337 - Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs(2011)
Authors: Ann Smeets, Anneleen Daemen, Isabelle Vanden Bempt, Olivier Gevaert, Bart Claes, Hans Wildiers, Diether Lambrechts, Bart De Moor, Patrick Neven, Robert Paridaens, et al.
Pages: 767 - 776 - Actinobaculum schaalii Causing Fournier's Gangrene(2011)
Authors: Isabelle Vanden Bempt
Pages: 2369 - 2371